(VIANEWS) – SKUE SPAREBANK (SKUE.OL), DSM KON (DSM.AS), ROBERTET (RBT.PA) are the highest sales growth and return on equity stocks on this list.
Here is a list of stocks with an above 5% expected next quarter sales growth, and a 3% or higher return on equity. May these stocks be a good medium-term investment option?
1. SKUE SPAREBANK (SKUE.OL)
17% sales growth and 9.06% return on equity
Skue Sparebank provides various banking products and services for individual and business in Norway. The company offers operating, tax deduction, capital, client, deposit, and group accounts; business, construction, personal, vehicle, and small loans, as well as mortgage, bank guarantee, overdraft, and leasing services; and home and leisure, car and other vehicles, pet, company and employees, agriculture insurance products. It also provides savings and pension products; and online and mobile banking, bank card, and payment services. The company was formerly known as Nes Prestegjelds Sparebank and changed its name to Skue Sparebank in October 2013. Skue Sparebank was founded in 1842 and is based in Geilo, Norway.
Earnings Per Share
As for profitability, SKUE SPAREBANK has a trailing twelve months EPS of kr82.41.
PE Ratio
SKUE SPAREBANK has a trailing twelve months price to earnings ratio of 2.69. Meaning, the purchaser of the share is investing kr2.69 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.06%.
Moving Average
SKUE SPAREBANK’s value is under its 50-day moving average of kr231.64 and higher than its 200-day moving average of kr220.59.
Sales Growth
SKUE SPAREBANK’s sales growth is 20% for the ongoing quarter and 17% for the next.
More news about SKUE SPAREBANK.
2. DSM KON (DSM.AS)
14.5% sales growth and 4.69% return on equity
Koninklijke DSM N.V., a science-based company, engages in health and nutrition businesses in the Netherlands, Switzerland, rest of Europe, North America, Latin America, China, rest of Asia, and internationally. It operates through Animal Nutrition & Health (ANH); Health, Nutrition & Care (HNC); and Food & Beverage segments. The Animal Nutrition & Health segment offers essential products, including vitamins, premixes, and carotenoids; performance solutions, such as enzymes, microbes, and eubiotics; precision services comprising support with data analysis to measure animal health and environmental footprint on farm level and feed safety; and methane reducing feed additive for ruminants. The Health, Nutrition & Care segment provides solutions for the early life nutrition, dietary supplement, pharmaceutical, medical nutrition, personal care and aroma, and biomedical materials markets. It offers vitamins, nutritional lipids, minerals, carotenoids, nutraceuticals, digestive enzymes, probiotics and prebiotics, active pharmaceutical ingredients, and sunscreen filters, as well as a range of biomedical solutions; premix, market-ready solutions, and personalized nutrition solutions; and regulatory affairs and formulation expertise, and customized solutions. The Food & Beverage segment provides ingredients and solutions for use in a range of food products, such as dairy; bakery, cereals, and bars; savory foods; beverages and brewing; confectionery and fruit; plant-based meat and fish alternatives; and petfood. The company was founded in 1902 and is headquartered in Heerlen, the Netherlands.
Earnings Per Share
As for profitability, DSM KON has a trailing twelve months EPS of €6.13.
PE Ratio
DSM KON has a trailing twelve months price to earnings ratio of 19.09. Meaning, the purchaser of the share is investing €19.09 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 4.69%.
More news about DSM KON.
3. ROBERTET (RBT.PA)
14.1% sales growth and 14.34% return on equity
Robertet SA produces and sells perfumes, aromas, and natural products. The company operates in three segments: Raw materials, Fragrances, and Flavors. It also produces organic essential oils and active ingredients. The company operates in North America, Europe, the Asia Pacific, South America, Caribbean, Africa, and the Middle East. Robertet SA was founded in 1850 and is headquartered in Grasse, France.
Earnings Per Share
As for profitability, ROBERTET has a trailing twelve months EPS of €33.98.
PE Ratio
ROBERTET has a trailing twelve months price to earnings ratio of 25.57. Meaning, the purchaser of the share is investing €25.57 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.34%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 20.6%, now sitting on 667.32M for the twelve trailing months.
More news about ROBERTET.
4. ASML HOLDING (ASML.AS)
11.2% sales growth and 74.04% return on equity
ASML Holding N.V. develops, produces, markets, sells, and services advanced semiconductor equipment systems consisting of lithography, metrology, and inspection systems for memory and logic chipmakers. The company provides extreme ultraviolet lithography systems; and deep ultraviolet lithography systems comprising immersion and dry lithography solutions to manufacture various range of semiconductor nodes and technologies. It also offers metrology and inspection systems, including YieldStar optical metrology solutions to assess the quality of patterns on the wafers; and HMI e-beam solutions to locate and analyze individual chip defects. In addition, the company provides computational lithography and lithography process and control software solutions; and refurbishes and upgrades older lithography systems, as well as offers customer support and associated services. It operates in Japan, South Korea, Singapore, Taiwan, China, rest of Asia, the Netherlands, rest of Europe, the Middle East, Africa, and the United States. The company was formerly known as ASM Lithography Holding N.V. and changed its name to ASML Holding N.V. in 2001. ASML Holding N.V. was founded in 1984 and is headquartered in Veldhoven, the Netherlands.
Earnings Per Share
As for profitability, ASML HOLDING has a trailing twelve months EPS of €17.38.
PE Ratio
ASML HOLDING has a trailing twelve months price to earnings ratio of 32.84. Meaning, the purchaser of the share is investing €32.84 for every euro of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 74.04%.
Moving Average
ASML HOLDING’s value is below its 50-day moving average of €591.57 and higher than its 200-day moving average of €545.50.
Volume
Today’s last reported volume for ASML HOLDING is 240129 which is 65.01% below its average volume of 686284.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Apr 28, 2023, the estimated forward annual dividend rate is 9.5 and the estimated forward annual dividend yield is 1.68%.
More news about ASML HOLDING.
5. NAVAMEDIC (NAVA.OL)
9.6% sales growth and 16.31% return on equity
Navamedic ASA, a pharmaceutical company, develops, produces, markets, and sells pharmaceuticals and related products in Northern Europe. The company's product portfolio includes prescription and non-prescription pharmaceuticals, as well as medical nutrition products, medical devices, food supplements, and cosmetics. It offers medical nutrition products for various therapeutic areas, including phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinemia, methylmalonic acidemia/propionic acidemia, glutaric aciduria, isovaleric acidemia, and urea cycle disorders, as well as products for glycogen storage diseases and renal diseases, fat metabolism, malnutrition, and ketogenic diet. In addition, the company provides consumer health products consisting of non-prescription drugs and health care products for pain relief, cough and cold, gastro, women's health, and others primarily through pharmacies and drugstores; specialty pharmaceutical products in various therapeutic areas comprising dermatology, wound care, women's health, urology, and obesity; and branded generics, including cardiology products and antibiotics. It sells, markets, and distributes its products to hospitals, patients, and pharmacies. The company was formerly known as Glucomed AS and changed its name to Navamedic ASA in 2004. Navamedic ASA was incorporated in 2002 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, NAVAMEDIC has a trailing twelve months EPS of kr0.45.
PE Ratio
NAVAMEDIC has a trailing twelve months price to earnings ratio of 83.33. Meaning, the purchaser of the share is investing kr83.33 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 16.31%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 28.6%, now sitting on 382.14M for the twelve trailing months.
Yearly Top and Bottom Value
NAVAMEDIC’s stock is valued at kr37.50 at 02:20 EST, way under its 52-week high of kr43.60 and way higher than its 52-week low of kr25.00.
Moving Average
NAVAMEDIC’s value is under its 50-day moving average of kr38.64 and higher than its 200-day moving average of kr34.23.
More news about NAVAMEDIC.
6. SPBK 1 NORDMØRE (SNOR.OL)
7.1% sales growth and 9.57% return on equity
SpareBank 1 Nordmøre provides various banking services in Norway. The company offers savings and deposit accounts; car, motorcycle, boat, and construction loans; and mortgages. It also provides business insurance products, which include liability, auto, mortgage, operating loss, asset, commercial, and project insurance products; personal insurance products, such as life, travel, and accidental insurance products; pension products; bank cards; payment and debt collection services; and mobile and online banking services. In addition, the company offers bank guarantees, trade credit products, and operating credit products for agriculture, as well as factoring, leasing, and repayment products and services. The company was founded in 1835 and is based in Kristiansund, Norway. SpareBank 1 Nordmøre is a subsidiary of SpareBank 1 Gruppen AS.
Earnings Per Share
As for profitability, SPBK 1 NORDMØRE has a trailing twelve months EPS of kr13.79.
PE Ratio
SPBK 1 NORDMØRE has a trailing twelve months price to earnings ratio of 8.92. Meaning, the purchaser of the share is investing kr8.92 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.57%.
Sales Growth
SPBK 1 NORDMØRE’s sales growth is 38.5% for the present quarter and 7.1% for the next.
Dividend Yield
As maintained by Morningstar, Inc., the next dividend payment is on Apr 6, 2022, the estimated forward annual dividend rate is 5 and the estimated forward annual dividend yield is 3.82%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 52.3%, now sitting on 771M for the twelve trailing months.
More news about SPBK 1 NORDMØRE.
7. MULTICONSULT (MULTI.OL)
5.1% sales growth and 32.89% return on equity
Multiconsult ASA provides engineering design, consultancy, and architecture services in Norway and internationally. The company offers multidisciplinary consultancy, design, planning, project supervision and management, geotechnical site survey, verification and control, analysis and due diligence, construction management, geological investigations, environmental services and HSE, river basin management, hydrometry, and hydrological field work services. It serves buildings and properties, cities and society, industry, oil and gas, renewable energy, rail and transportation, and water and environment sectors. Multiconsult ASA was founded in 1908 and is headquartered in Oslo, Norway.
Earnings Per Share
As for profitability, MULTICONSULT has a trailing twelve months EPS of kr11.25.
PE Ratio
MULTICONSULT has a trailing twelve months price to earnings ratio of 13.29. Meaning, the purchaser of the share is investing kr13.29 for every norwegian krone of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.89%.
Moving Average
MULTICONSULT’s worth is higher than its 50-day moving average of kr143.81 and way higher than its 200-day moving average of kr135.56.
Earnings Before Interest, Taxes, Depreciation, and Amortization
MULTICONSULT’s EBITDA is 35.38.
More news about MULTICONSULT.
